Jerry Bagel, M.D., M.S. and Alexa Hetzel, M.S., PA-C discuss an overview of plaque psoriasis and how plaque psoriasis impacts quality of life.

Dr. Jerry Bagel and physician assistant, Alexa Hetzel, comment on the burden of plaque psoriasis and what options are available for the treatment of plaque psoriasis.

Jerry Bagel, MD, MS, discusses the mechanism of action of biologics used in plaque psoriasis.

Jerry Bagel, MD, MS, and Alexa Hetzel, MS, PA-C, discuss their experiences with biologics used to treat plaque psoriasis.

Experts in plaque psoriasis discuss how to select a biologic based on patient factors and comorbidities.

Panelists talk about when they might consider switching biologics for patients with plaque psoriasis.

Jerry Bagel, MD, MS, and Alexa Hetzel, MS, PA-C, discuss the safety and efficacy of deucravacitinib in patients with plaque psoriasis.

Dr Jerry Bagel and physician assistant Alexa Hetzel comment on other agents available for the treatment of plaque psoriasis.

Jerry Bagel, MD, MS, and Alexa Hetzel, MS, PA-C, touch on unmet needs that remain in the treatment of plaque psoriasis.

Experts in plaque psoriasis discuss how patients are referred to them for treatment.

Jerry Bagel, MD, MS, discusses the relationship between a physician and physician assistant treating plaque psoriasis.

Experts in plaque psoriasis discuss the impact of access to medication for plaque psoriasis and how biosimilars might impact the treatment of plaque psoriasis.

Dr Jerry Bagel and physician assistant Alexa Hetzel comment on the impact of COVID-19 pandemic on patients with plaque psoriasis.

Jerry Bagel, MD, MS, and Alexa Hetzel, MS, PA-C, discuss how clinical trials play an important role in the management of plaque psoriasis.

Experts in plaque psoriasis discuss the future for the management of plaque psoriasis.